You are using an outdated browser. Please upgrade your browser to improve your experience.

hereditary spastic paraplegia 57

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description An extremely rare, complex type of hereditary spastic paraplegia, characterized by onset in infancy of pronounced leg spasticity (leading to the inability to walk independently), reduced visual acuity due to optic atrophy, and distal wasting of the hands and feet due to an axonal demyelinating sensorimotor neuropathy. SPG57 is caused by mutations in the TFG gene (3q12.2) encoding protein TFG, which is thought to play a role in ER microtubular architecture and function.
Uniprot Description A complicated form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations.
Disease Ontology Description A hereditary spastic paraplegia that has_material_basis_in mutation in the TFG gene on chromosome 3q12.
Mondo Term and Equivalent IDs
MONDO:0014295:  hereditary spastic paraplegia 57
EFO:0009017: 
Orphanet:431329: 
SCTID:723826007: 
UMLS:C3714897: 
UMLS:C4510084: